Blog

There are plenty of investing strategies you can use when choosing a stock to buy. Some investors may be looking for more stability, others want solid dividends for years to come, and others may be

While McDonald's (NYSE: MCD) recent earnings miss isn't the end of the world, the larger trends within the company suggest the bullish run the company has experienced has limits. Yes, the stock has

Chances are that you'd struggle to find a more attractive growth opportunity over the next 10 years than legal cannabis. Sales in the global pot industry more than tripled over the previous four

According to Moody's, the chances of a recession hitting within the next 12 to 18 months are "awfully high." The International Monetary Fund has reduced its global economic growth forecast estimate

Are you worried about healthcare-sector stocks?

Considering their performance lately, some nervousness is understandable. The S&P 500 index has climbed 9.8% higher over the past twelve months, but

Over the last decade, mobile devices have dramatically changed the way people shop and communicate, but the next 10 years could see even more radical change thanks to advancements in artificial

A U.S. Army contract competition for a truck that can be parachuted out of a plane and driven off with an infantry squad has been narrowed to three finalists that are expected to deliver prototypes

At this time one year ago, cannabis stocks were seated high on the mountain top overlooking nearly all other industries and sectors. The marijuana industry simply couldn't be stopped, with Canada

HEXO (NYSE: HEXO) is reducing its employee numbers. The company announced Thursday that it's eliminating roughly 200 jobs due to what it terms "a changing market and regulatory environment."

The

I've maintained for quite a while that Vertex Pharmaceuticals (NASDAQ: VRTX) is the best biotech stock on the market. My thinking was -- and is -- that Vertex's virtual monopoly in the cystic

It hasn't been a great year for pharma companies. The industry, as measured by the SPDR S&P Pharmaceuticals Index, is up less than 1.5% since the beginning of the year, a period during which the S&P

TikTok's user base, which skews strongly toward younger demographics, continues to soar. The short-form music and karaoke app has emerged as a viable challenger to Facebook's (NASDAQ: FB) dominance

Wingstop's (NASDAQ: WING) stock has more than quadrupled since its IPO in 2015 as the chicken wing chain has repeatedly impressed investors with its consistent same-store sales growth, aggressive

Expectations were high going into Microsoft's (NASDAQ: MSFT) earnings report. The company has stubbornly clung to its $1 trillion market cap, a watermark it achieved earlier this year. Microsoft has

Global lithium markets sure have been moody lately. On the one hand, the world will need to significantly increase production of lithium materials by the end of the 2020s to keep pace with soaring

If you're in the market for a new job, you're probably aware that a solid resume could be your ticket to an exciting offer. Specifically, the skills you detail on your resume could drive recruiters

Ready or not, election season is beginning to ramp up, more than a full year ahead of the presidential election on Nov. 3, 2020. The future of a lot of programs and government spending is clearly on

Just a few years ago, Black Friday still meant something. Some retailers might start displaying their Christmas decorations a bit earlier, but it wasn't until the day after Thanksgiving that they'd

Illumina (NASDAQ: ILMN) downright disappointed investors with its second-quarter results in July, reporting slowing revenue growth and a year-over-year decline in adjusted earnings. However, CEO

Has Gilead Sciences (NASDAQ: GILD) really turned the corner after several years of sinking revenue and earnings? That was the question for investors as the big biotech prepared to provide an update

Despite a horrible start, 2019 has turned out to be a reasonably good year so far for ResMed (NYSE: RMD). The healthcare company has consistently beaten Wall Street earnings estimates in recent

Cerner (NASDAQ: CERN) has quietly become a solid winner so far in 2019. Shares of the healthcare technology company are handily beating the broader market indexes. Cerner has met or beat Wall Street

Pharmaceutical giant Novartis (NYSE: NVS) has seen a strong performance so far in 2019. While the company has been outperformed by rivals like Amgen, Novartis has edged out over other competitors

Image source: The Motley Fool.

Arthur J. Gallagher & Co. (NYSE: AJG)Q3 2019 Earnings CallOct 24, 2019, 5:15 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

CMS Energy (NYSE: CMS)Q3 2019 Earnings CallOct 24, 2019, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com